सदस्य:Dinesh smita/प्रयोगपृष्ठ

मुक्त ज्ञानकोश विकिपीडिया से
Dinesh smita/प्रयोगपृष्ठ
Box containing 100 COVID-19 Vaccine AstraZeneca doses
Vaccine description
TargetSARS-CoV-2
Vaccine typeViral vector
Clinical data
Trade namesVaxzevria,[1] Covishield[2][3]
Other namesAZD1222,[4][5]
ChAdOx1 nCoV-19,[6]
ChAdOx1-S,[7]
COVID-19 Vaccine AstraZeneca,[8][9]
AstraZeneca COVID-19 Vaccine,[10]
License data
Pregnancy
category
Routes of
administration		Intramuscular
ATC code
  • None
Legal status
Legal status
  • AU: S4 (Prescription only) [7]
  • CA: Schedule D; Authorized by interim order [10][11]
  • UK: Conditional and temporary authorisation to supply [9][12]
  • EU: Conditional marketing authorisation [1][13][14]
  • KR, BR – Approved[15][16]

IND, INA,[17] BD, AG, SV, DOM,

TU,MEX, NE, SL, SRB:[18] Emergency Authorization only
Identifiers
CAS Number
DrugBank
UNII
  1. ↑ अ आ "Vaxzevria (previously COVID-19 Vaccine AstraZeneca) EPAR". European Medicines Agency (EMA). Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  2. ↑ सन्दर्भ त्रुटि: <ref> का गलत प्रयोग; CA About नाम के संदर्भ में जानकारी नहीं है।
  3. ↑ "Already produced 40–50 million dosages of Covishield vaccine, says Serum Institute". The Hindu. 28 December 2020.
  4. ↑ सन्दर्भ त्रुटि: <ref> का गलत प्रयोग; AstraZeneca_PR नाम के संदर्भ में जानकारी नहीं है।
  5. ↑ सन्दर्भ त्रुटि: <ref> का गलत प्रयोग; AZ CDC ACIP नाम के संदर्भ में जानकारी नहीं है।
  6. ↑ AstraZeneca and Oxford University announce landmark agreement for COVID-19 vaccine. प्रेस रिलीज़. 30 April 2020. https://www.astrazeneca.com/media-centre/press-releases/2020/astrazeneca-and-oxford-university-announce-landmark-agreement-for-covid-19-vaccine.html. अभिगमन तिथि: 13 January 2021. 
  7. ↑ अ आ इ "COVID-19 Vaccine AstraZeneca PI". Therapeutic Goods Administration (TGA).
  8. ↑ अ आ "COVID-19 Vaccine AstraZeneca". Therapeutic Goods Administration (TGA). 16 February 2021. अभिगमन तिथि 16 February 2021.
  9. ↑ अ आ "Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca". Medicines and Healthcare products Regulatory Agency (MHRA). 30 December 2020. अभिगमन तिथि 4 January 2021.
  10. ↑ अ आ "Regulatory Decision Summary - AstraZeneca COVID-19 Vaccine". Health Canada. 26 February 2021. अभिगमन तिथि 26 February 2021.
  11. ↑ "AstraZeneca COVID-19 Vaccine monograph" (PDF). AstraZeneca. 26 February 2021.
  12. ↑ "Conditions of Authorisation for COVID-19 Vaccine AstraZeneca". Medicines and Healthcare products Regulatory Agency (MHRA). 30 December 2020. अभिगमन तिथि 4 January 2021.
  13. ↑ सन्दर्भ त्रुटि: <ref> का गलत प्रयोग; EMA recommendation नाम के संदर्भ में जानकारी नहीं है।
  14. ↑ European Commission authorises third safe and effective vaccine against COVID-19. प्रेस रिलीज़. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_306. अभिगमन तिथि: 29 January 2021. 
  15. ↑ "아스트라제네카社 코로나19 백신 품목허가" [AstraZeneca's Corona 19 vaccine product license]. 식품의약품안전처 (कोरियाई में). 식품의약품안전처. 10 February 2021. अभिगमन तिथि 10 February 2021.
  16. ↑ "Anvisa aprova registro definitivo da vacina de Oxford no Brasil" [Anvisa approves definitive registration of Oxford vaccine in Brazil]. G1 (पुर्तगाली में). 12 March 2021. अभिगमन तिथि 20 March 2021.
  17. ↑ "BPOM Terbitkan Izin Penggunaan Darurat Vaksin Covid-19 AstraZeneca" [BPOM Issues AstraZeneca Covid-19 Vaccine Emergency Use Permit]. Kompas.com. 10 March 2021. अभिगमन तिथि 10 March 2021.
  18. ↑ "150,000 doses of AstraZeneca vaccine arrive in Serbia". Government of Serbia. 21 February 2021. अभिगमन तिथि 2 March 2021.
"https://hi.wikipedia.org/w/index.php?title=सदस्य:Dinesh_smita/प्रयोगपृष्ठ&oldid=5165478" से प्राप्त